![Anna Hemnes, MD](/-/media/Non-Clinical/Images/System-Images/Profile-Images/H/Hemnes_Anna.png)
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), united therapeutics(SIGNIFICANT), GossamerBio(MODEST), Janssen Pharmaceuticals, Inc(SIGNIFICANT), Merck(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Tenax Therapeutics(SIGNIFICANT)